Literature DB >> 16155869

Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents.

Mark Allen1, Jeff W M Bulte, Lars Liepold, Gautam Basu, Holly A Zywicke, Joseph A Frank, Mark Young, Trevor Douglas.   

Abstract

In order to compensate for the inherent high threshold of detectability of MR contrast agents, there has been an active interest in the development of paramagnetic nanoparticles incorporating high payloads of Gd(3+) with high molecular relaxivities. Toward this end, the protein cage of Cowpea chlorotic mottle virus (CCMV), having 180 metal binding sites, is being explored. In vivo CCMV binds Ca(2+) at specific metal binding sites; however, Gd(3+) can also bind at these sites. Using fluorescence resonance energy transfer we have characterized the binding affinity of Gd(3+) to the metal binding sites by competition experiments with Tb(3+). The measured dissociation constant (K(d)) for Gd(3+) bound to the virus is 31 microM. The T(1) and T(2) relaxivities of solvent water protons in the presence of Gd(3+)-bound CCMV were 202 and 376 mM(-1) s(-1), respectively, at 61 MHz Larmor frequency. The unusually high relaxivity values of the Gd(3+)-CCMV are largely a result of the nanoparticle virus size and the large number of Gd(3+) ions bound to the virus. These preliminary results should encourage further investigations into the use of viral protein cages as a new platform for MR contrast agents. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155869     DOI: 10.1002/mrm.20614

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  49 in total

1.  Self-assembly and optically triggered disassembly of hierarchical dendron-virus complexes.

Authors:  Mauri A Kostiainen; Oksana Kasyutich; Jeroen J L M Cornelissen; Roeland J M Nolte
Journal:  Nat Chem       Date:  2010-03-21       Impact factor: 24.427

2.  Human ferritin cages for imaging vascular macrophages.

Authors:  Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell
Journal:  Biomaterials       Date:  2010-11-11       Impact factor: 12.479

Review 3.  Non-invasive genetic imaging for molecular and cell therapies of cancer.

Authors:  C Belmar; P-W So; G Vassaux; V Moleiro-Sanemeterio; P Martín-Duque
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

Review 4.  The art of engineering viral nanoparticles.

Authors:  Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

Review 5.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 6.  Molecular imaging with nanoparticles: giant roles for dwarf actors.

Authors:  Paul Debbage; Werner Jaschke
Journal:  Histochem Cell Biol       Date:  2008-09-30       Impact factor: 4.304

7.  Polyvalent display of heme on hepatitis B virus capsid protein through coordination to hexahistidine tags.

Authors:  Duane E Prasuhn; Jane Kuzelka; Erica Strable; Andrew K Udit; So-Hye Cho; Gabriel C Lander; Joel D Quispe; James R Diers; David F Bocian; Clint Potter; Bridget Carragher; M G Finn
Journal:  Chem Biol       Date:  2008-05

8.  Use of a genetically engineered protein for the design of a multivalent MRI contrast agent.

Authors:  Lindsay S Karfeld; Steve R Bull; Nicolynn E Davis; Thomas J Meade; Annelise E Barron
Journal:  Bioconjug Chem       Date:  2007-10-10       Impact factor: 4.774

9.  Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents.

Authors:  Michael A Bruckman; Stephen Hern; Kai Jiang; Chris A Flask; Xin Yu; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2013-03-14       Impact factor: 6.331

Review 10.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.